| Product Code: ETC11944585 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 & 2031F |
3.3 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Industry Life Cycle |
3.4 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Porter's Five Forces |
3.5 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.7 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
4 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of obesity, type II diabetes, and NASH in France |
4.2.2 Technological advancements in endoscopy devices leading to more effective treatments |
4.2.3 Growing awareness about the benefits of endoscopic procedures for these conditions |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of endoscopy devices |
4.3.2 High cost associated with endoscopic procedures for obesity, type II diabetes, and NASH |
4.3.3 Limited reimbursement options for endoscopic treatments in France |
5 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Trends |
6 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Types |
6.1 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Endoscope, 2021 - 2031F |
6.1.4 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Mechanical endoscopic equipment, 2021 - 2031F |
6.1.5 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Visualization and documentation systems, 2021 - 2031F |
6.1.6 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Accessories, 2021 - 2031F |
6.1.7 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Other endoscopy equipment , 2021 - 2031F |
6.2 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Gastric balloon, 2021 - 2031F |
6.2.3 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Aspiration therapy, 2021 - 2031F |
6.2.4 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Endoscopic sleeve gastroplasty, 2021 - 2031F |
6.2.5 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Gastric injection, 2021 - 2031F |
6.2.6 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Lap band surgery , 2021 - 2031F |
6.3 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Obesity , 2021 - 2031F |
6.3.3 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Type II Diabetes , 2021 - 2031F |
6.3.4 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Nonalcoholic Steatohepatitis (NASH, 2021 - 2031F |
7 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Import-Export Trade Statistics |
7.1 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Export to Major Countries |
7.2 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Imports from Major Countries |
8 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Key Performance Indicators |
8.1 Average procedure time reduction with the use of advanced endoscopy devices |
8.2 Rate of adoption of endoscopic procedures for obesity, type II diabetes, and NASH |
8.3 Patient satisfaction scores post-endoscopic treatment |
9 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Opportunity Assessment |
9.1 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.3 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Competitive Landscape |
10.1 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenue Share, By Companies, 2024 |
10.2 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here